Cancidas and septic shock 
Cancidas and septic shock Patient Reports February 10, 2012
Cancidas Side Effects Report #4848954-3
Cancidas side effect was reported by a Physician from GERMANY on Nov 29, 2005. Male patient, 66 years of age, was diagnosed with systemic candida and was treated with Cancidas. After drug was administered, patient experienced the following side effects: aspergillosis, multi-organ failure, pleural effusion, pneumonia
, pulmonary haemorrhage, renal failure, respiratory failure, septic shock, systemic candida. Cancidas dosage: unknown. During the same period patient was treated with AMPHOTERICIN B, AMPHOTERICIN B, VORICONAZOLE. Patient died.Cancidas Side Effects Report #5097757-6
Cancidas side effect was reported by a Consumer or non-health professional from BRAZIL on Aug 28, 2006. Female patient, 54 years of age, was diagnosed with systemic candida and was treated with Cancidas. After drug was administered, patient experienced the following side effects: abdominal tenderness, acute respiratory distress syndrome, bowel sounds abnormal, respiratory failure, septic shock. Cancidas dosage: unknown. Patient died.
Cancidas Side Effects Report #5528591-8
Cancidas side effect was reported by a Consumer or non-health professional from GERMANY on Nov 14, 2007. Male patient, 53 years of age, was diagnosed with systemic candida and was treated with Cancidas. After drug was administered, patient experienced the following side effects: enterococcal sepsis, hepatitis toxic, septic shock. Cancidas dosage: unknown. During the same period patient was treated with ALBUMIN, AMIODARAONE, BISOPROLOL FUMARATE, BUTYLSCOPOLAMINE BROMIDE, CHOLECALCIFEROL. Patient died.
Cancidas Side Effects Report #5739708-4
Cancidas side effect was reported by a Consumer or non-health professional from GERMANY on May 01, 2008. Male patient, 53 years of age, was diagnosed with systemic candida and was treated with Cancidas. After drug was administered, patient experienced the following side effects: circulatory collapse, disease progression, hepatitis toxic, hypotension, infection
, pancreatic pseudocyst, septic shock. Cancidas dosage: 150 MG/DAILY IV. During the same period patient was treated with ALBUMIN, AMINO ACIDS, AMIODARONE, BISOPROLOL FUMARATE, BUTYLSCOPOLAMINE BROMIDE, CALCIUM, CHOLECALCIFEROL. Patient died.Cancidas Side Effects Report #4966368-2
Cancidas side effect was reported by a Health Professional from CANADA on Mar 28, 2006. Female patient, 45 years of age, was diagnosed with systemic candida, septic shock and was treated with Cancidas. After drug was administered, patient experienced the following side effects: abdominal abscess, catheter related infection, lower gastrointestinal haemorrhage, septic shock, systemic candida. Cancidas dosage: unknown. Patient was hospitalized. Patient died.
Cancidas Side Effects Report #4773212-5
Cancidas side effect was reported by a Physician from SLOVENIA on Sept 09, 2005. Male patient, 58 years of age, weighting 176.4 lb, was diagnosed with sepsis
and was treated with Cancidas. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, hepatocellular damage, septic shock, transaminases increased. Cancidas dosage: unknown. During the same period patient was treated with AMIKACIN, VANCOMYCIN. Patient died on 04/11/2005.Cancidas Side Effects Report #5332294-2
Cancidas side effect was reported by a Physician from SPAIN on May 14, 2007. Female patient, 69 years of age, weighting 165.3 lb, was diagnosed with peritonitis, pancreatitis haemorrhagic, surgery
, microbiology test, evidence based treatment and was treated with Cancidas. After drug was administered, patient experienced the following side effects: septic shock, thrombocytopenia. Cancidas dosage: unknown. During the same period patient was treated with MEROPENEM, LINEZOLID, CILASTATIN AND IMIPENEM, CILASTATIN AND IMIPENEM. Patient died on 03/29/2007.Cancidas Side Effects Report #5724208-8
Cancidas side effect was reported by a Physician from AUSTRIA on Apr 24, 2008. Male patient, 39 years of age, was diagnosed with infection
and was treated with Cancidas. After drug was administered, patient experienced the following side effects: septic shock. Cancidas dosage: unknown. During the same period patient was treated with AMPHOTERICIN B, POSACONAZOLE. Patient was hospitalized. Patient died.Cancidas Side Effects Report #4832165-1
Cancidas side effect was reported by a Consumer or non-health professional from SPAIN on Nov 02, 2005. Female patient, 52 years of age, was diagnosed with fungal infection
, renal transplant and was treated with Cancidas. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, hepatic failure, septic shock. Cancidas dosage: unknown. During the same period patient was treated with TACROLIMUS, CEFEPIME, COLISTIN, METHYLPREDNISOLONE. Patient died.Cancidas Side Effects Report #4844706-9
Cancidas side effect was reported by a Consumer or non-health professional from SPAIN on Nov 16, 2005. Female patient, 52 years of age, was diagnosed with fungal infection
, renal transplant and was treated with Cancidas. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, haemodialysis, hepatic failure, renal cyst, septic shock. Cancidas dosage: 70 MG/DAILY IV ; 50 MG/DAILY IV ; 35 MG/DAILY IV. During the same period patient was treated with TACROLIMUS, CEFEPIME, COLISTIN, METHYLPREDNISOLONE. Patient died.Cancidas Side Effects Report #4924877-6
Cancidas side effect was reported by a Physician from INDIA on Feb 04, 2006. Female patient, 44 years of age, was diagnosed with febrile neutropenia and was treated with Cancidas. After drug was administered, patient experienced the following side effects: bradycardia, bronchopneumonia, cardio-respiratory arrest, headache
, pain in jaw, pancytopenia, septic shock. Cancidas dosage: unknown. During the same period patient was treated with AMIKACIN SULPHATE, CLOTRIMAZOLE, MEROPENEM, TEICOPLANIN. Patient died.Cancidas Side Effects Report #5762707-3
Cancidas side effect was reported by a Physician from AUSTRIA on May 30, 2008. Female patient, 49 years of age, weighting 99.21 lb, was diagnosed with evidence based treatment, prophylaxis, immunosuppression, systemic antifungal treatment and was treated with Cancidas. After drug was administered, patient experienced the following side effects: septic shock. Cancidas dosage: unknown. During the same period patient was treated with PIPERACILLIN AND TAZOBACTAM, AZATHIOPRINE, ANTILYMPHOCYTE IMMUNOGLOBULIN, METHYLPREDNISOLONE, FLUCONAZOLE, VANCOMYCIN, MEROPENEM, CIPROFLOXACIN. Patient died.
Cancidas Side Effects Report #4808087-9
Cancidas side effect was reported by a Physician from ITALY on Oct 12, 2005. Female patient, 16 years of age, was diagnosed with candidiasis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: plasma cells decreased, pseudomonas infection, septic shock, zygomycosis. Cancidas dosage: unknown. Patient was hospitalized. Patient died.
Cancidas Side Effects Report #5048571-9
Cancidas side effect was reported by a Consumer or non-health professional from PORTUGAL on June 22, 2006. Female patient, 46 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: condition aggravated, hepatic failure, hepatic necrosis, hypotension, septic shock. Cancidas dosage: 50 MG/DAILY IV. During the same period patient was treated with INJ ACETAMINOPHEN, INJ ACETAMINOPHEN, INJ ACETAMINOPHEN, INJ ACETAMINOPHEN, INJ ACETAMINOPHEN, INJ ACETAMINOPHEN, INJ ACETAMINOPHEN, INJ ACETAMINOPHEN. Patient died.
Cancidas Side Effects Report #5090883-7
Cancidas side effect was reported by a Health Professional from PORTUGAL on Aug 07, 2006. Female patient, 46 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: hepatic failure, hepatic necrosis, septic shock. Cancidas dosage: 50 MG/DAILY IV. During the same period patient was treated with CYTARABINE, PIPERACILLIN AND TAZOBACTAM, AMIKACIN, ACETAMINOPHEN. Patient recovered.
Cancidas Side Effects Report #5023777-3
Cancidas side effect was reported by a Physician from PORTUGAL on May 18, 2006. Female patient, 46 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: hepatic failure, septic shock. Cancidas dosage: 50 MG/DAILY IV. During the same period patient was treated with AMIKACIN, CYTARABINE, PIPERACILLIN. Patient died.
Cancidas Side Effects Report #5031653-5
Cancidas side effect was reported by a Physician from PORTUGAL on June 06, 2006. Female patient, 46 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: hepatic failure, hepatic necrosis, septic shock. Cancidas dosage: 50 MG/DAILY IV. During the same period patient was treated with AMIKACIN, CYTARABINE, PIPERACILLIN. Patient died.
Cancidas Side Effects Report #4714577-X
Cancidas side effect was reported by a Physician from BELGIUM on July 01, 2005. Male patient, 34 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: respiratory failure, septic shock. Cancidas dosage: unknown. Patient died.
Cancidas Side Effects Report #4722806-1
Cancidas side effect was reported by a Physician from BELGIUM on July 01, 2005. Male patient, 34 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: respiratory failure, septic shock. Cancidas dosage: unknown. Patient died.
Cancidas Side Effects Report #4724202-X
Cancidas side effect was reported by a Physician from BELGIUM on July 01, 2005. Male patient, 34 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: respiratory failure, septic shock. Cancidas dosage: unknown. Patient died.
Cancidas Side Effects Report #4887414-0
Cancidas side effect was reported by a Physician from KOREA, REPUBLIC OF on Jan 04, 2006. Female patient, 29 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, septic shock. Cancidas dosage: 70 MG/DAILY, IV. During the same period patient was treated with INJ CANCIDAS, AMIKACIN SULPHATE, CEFTAZIDIME, IMIPENEM, ROXITHROMYCIN, TEICOPLANIN. Patient died.
Cancidas Side Effects Report #5296757-0
Cancidas side effect was reported by a Health Professional from SWITZERLAND on Feb 12, 2007. Female patient, 15 years of age, weighting 103.6 lb, was diagnosed with bronchopulmonary aspergillosis, acute lymphocytic leukaemia and was treated with Cancidas. After drug was administered, patient experienced the following side effects: arthritis
, extraskeletal ossification, mobility decreased, polyserositis, septic shock. Cancidas dosage: unknown. During the same period patient was treated with VFEND, ANTRA, ENOXAPARIN, INDOMETHACIN, NOPIL, MERCAPTOPURINE, METHOTREXATE. Patient recovered.Cancidas Side Effects Report #5022499-2
Cancidas side effect was reported by a Consumer or non-health professional from BELGIUM on May 15, 2006. Male patient was diagnosed with bronchopulmonary aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, condition aggravated, septic shock. Cancidas dosage: unknown. During the same period patient was treated with VFEND. Patient died.
Cancidas Side Effects Report #5290267-2
Cancidas side effect was reported by a Physician from SPAIN on Mar 28, 2007. Female patient, 63 years of age, was diagnosed with aspergillosis, bronchopulmonary aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, septic shock. Cancidas dosage: unknown. During the same period patient was treated with VORICONAZOLE, TACROLIMUS. Patient died.
Cancidas Side Effects Report #5293844-8
Cancidas side effect was reported by a Physician from SPAIN on Mar 28, 2007. Female patient, 63 years of age, was diagnosed with aspergillosis, bronchopulmonary aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, multi-organ failure, septic shock. Cancidas dosage: unknown. During the same period patient was treated with VORICONAZOLE, TACROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE. Patient died.
Cancidas Side Effects Report #5328077-X
Cancidas side effect was reported by a Physician from SPAIN on May 08, 2007. Female patient, 63 years of age, weighting 154.3 lb, was diagnosed with aspergillosis, bronchopulmonary aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, multi-organ failure, septic shock. Cancidas dosage: unknown. During the same period patient was treated with VORICONAZOLE, TACROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE. Patient died on 02/22/2007.
Cancidas Side Effects Report #5351525-6
Cancidas side effect was reported by a Physician from KOREA, REPUBLIC OF on May 28, 2007. Male patient, 61 years of age, weighting 147.7 lb, was diagnosed with aspergillosis, pneumonia
, gastritis prophylaxis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: septic shock. Cancidas dosage: unknown. During the same period patient was treated with TAZOCIN, AMPHOTERICIN B, LEVOFLOXACIN, DEXAMETHASONE, RANITIDINE, PHAZYME, OXOLAMINE, AMBROXOL. Patient recovered.Cancidas Side Effects Report #5379419-0
Cancidas side effect was reported by a Physician from KOREA, REPUBLIC OF on June 28, 2007. Male patient, 61 years of age, weighting 147.7 lb, was diagnosed with aspergillosis, pneumonia
, gastritis prophylaxis, dyspepsia and was treated with Cancidas. After drug was administered, patient experienced the following side effects: septic shock. Cancidas dosage: unknown. During the same period patient was treated with PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN AND TAZOBACTAM, AMPHOTERICIN B, LEVOFLOXACIN, DEXAMETHASONE, RANITIDINE, SIMETHICONE. Patient died on 06/17/2007.Cancidas Side Effects Report #5444930-0
Cancidas side effect was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on Aug 22, 2007. Male patient, 60 years of age, was diagnosed with aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, acute respiratory distress syndrome, condition aggravated, pneumonia fungal, pulmonary haemorrhage, septic shock. Cancidas dosage: 70 MG DAILY IV, 50 MG DAILY IV. During the same period patient was treated with AMIKACIN SULPHATE, CEFTAZIDIME, CLINDAMYCIN PHOSPHATE, IMIPENEM, ITRACONAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, TEICOPLANIN. Patient was hospitalized and became disabled. Patient died.
Cancidas Side Effects Report #5450964-2
Cancidas side effect was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on Sept 06, 2007. Male patient, 60 years of age, was diagnosed with aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, acute respiratory distress syndrome, condition aggravated, pneumonia fungal, pulmonary haemorrhage, septic shock. Cancidas dosage: 70 MG/DAILY IV; 50 MG/DAILY IV. During the same period patient was treated with AMIKACIN SULPHATE, CEFTAZIDIME, CLINDAMYCIN PHOSPHATE, IMIPENEM, ITRACONAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, TEICOPLANIN. Patient was hospitalized and became disabled. Patient died.
Cancidas Side Effects Report #6085434-4
Cancidas side effect was reported by a Physician from SPAIN on Feb 11, 2009. Male patient, 57 years of age, was diagnosed with aspergillosis, mediastinitis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: aspergillosis, encephalopathy, endotracheal intubation complication, hepatic function abnormal, lung infection pseudomonal, mechanical ventilation complication, multi-organ failure, septic shock, systemic mycosis. Cancidas dosage: 70 MG/1X, IV; 50 MG DAILY, IV. During the same period patient was treated with INSULIN, MEROPENEM, VANCOMYCIN. Patient died.
Cancidas Side Effects Report #5385968-1
Cancidas side effect was reported by a Physician from AUSTRIA on July 05, 2007. Female patient, 49 years of age, weighting 99.21 lb, was diagnosed with aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: septic shock, systemic mycosis. Cancidas dosage: unknown. During the same period patient was treated with VORICONAZOLE, PIPERACILLIN AND TAZOBACTAM, VANCOMYCIN, FLUCONAZOLE, MEROPENEM, CIPROFLOXACIN. Patient was hospitalized. Patient died on 05/01/2006.
Cancidas Side Effects Report #5010232-X
Cancidas side effect was reported by a Physician from AUSTRIA on Apr 21, 2006. Female patient, 49 years of age, was diagnosed with aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: septic shock, systemic mycosis. Cancidas dosage: unknown. During the same period patient was treated with VORICONAZOLE, PIPERACILLIN AND TAZOBACTAM, VANCOMYCIN, FLUCONAZOLE, MEROPENEM, CIPROFLOXACIN. Patient was hospitalized. Patient died on 05/01/2006.
Cancidas Side Effects Report #5310544-6
Cancidas side effect was reported by a Physician from BELGIUM on Apr 17, 2007. Female patient, 31 years of age, was diagnosed with aspergillosis, tuberculosis
, histiocytosis haematophagic, mycoplasma infection, cytomegalovirus infection and was treated with Cancidas. After drug was administered, patient experienced the following side effects: cerebral aspergillosis, hepatic cirrhosis, hepatic failure, septic shock. Cancidas dosage: unknown. During the same period patient was treated with VORICONAZOLE, ETHAMBUTOL HYDROCHLORIDE, GLOBULIN, CLARITHROMYCIN, GANCICLOVIR, ISONIAZID AND PYRAZINAMIDE AND RIFAMPIN. Patient died on 11/26/2005.Cancidas Side Effects Report #5314832-9
Cancidas side effect was reported by a Physician from BELGIUM on Apr 17, 2007. Female patient, 31 years of age, was diagnosed with aspergillosis, tuberculosis
, histiocytosis haematophagic, mycoplasma infection, cytomegalovirus infection and was treated with Cancidas. After drug was administered, patient experienced the following side effects: cerebral aspergillosis, hepatic cirrhosis, hepatic failure, septic shock. Cancidas dosage: unknown. During the same period patient was treated with VORICONAZOLE, ETHAMBUTOL HYDROCHLORIDE, GLOBULIN, CLARITHROMYCIN, GANCICLOVIR, ISONIAZID AND PYRAZINAMIDE AND RIFAMPIN. Patient died on 11/26/2005.Cancidas Side Effects Report #5330099-X
Cancidas side effect was reported by a Physician from BELGIUM on May 11, 2007. Female patient, 31 years of age, was diagnosed with aspergillosis, tuberculosis
, histiocytosis haematophagic, mycoplasma infection, cytomegalovirus infection and was treated with Cancidas. After drug was administered, patient experienced the following side effects: cerebral aspergillosis, hepatic cirrhosis, hepatic failure, septic shock. Cancidas dosage: unknown. During the same period patient was treated with VORICONAZOLE, ETHAMBUTOL HYDROCHLORIDE, GLOBULIN, CLARITHROMYCIN, GANCICLOVIR, ISONIAZID AND PYRAZINAMIDE AND RIFAMPIN. Patient died on 11/26/2005.Cancidas Side Effects Report #4882599-4
Cancidas side effect was reported by a Physician from UNITED STATES on Jan 10, 2006. Male patient, 19 years of age, was treated with Cancidas. After drug was administered, patient experienced the following side effects: pneumonia
, respiratory failure, septic shock, trichosporon infection. Cancidas dosage: unknown. During the same period patient was treated with METRONIDAZOLE, VORICONAZOLE, AMPHOTERICIN B AND CHOLESTEROL AND DISTEAROYLPHOSPHATIDYLGLYCEROL AND. Patient was hospitalized. Patient died.